NFKB1 and chronic obstructive pulmonary disease: NF-κB activation in patients with COPD occurs in response to inflammatory mediators such as IL-1β and TNF-α or due to activation of Toll-like receptors (TLRs) following bacterial or viral infections (Edwards et al., 2009).